Founder and CEO Kristina Cahojova says the idea behind kegg began in 2016 after she was asked to track cervical mucus and found the existing process manual and difficult to interpret. The company developed that problem into a connected fertility-monitoring product built around repeated measurements of changes in the vaginal environment.
The current kegg system combines a reusable intravaginal sensor with a mobile app. The company describes the device as an FDA-registered medical device; that wording should not be confused with FDA approval or clearance for every marketing claim. The product is intended to provide fertility and cycle insights, not to diagnose infertility or replace evaluation by a healthcare professional.
The app records measurements over time and presents trends intended to help users identify changes associated with the fertile window. Results can be affected by individual physiology and correct use, so users should follow the official user manual and seek clinical advice when they have medical concerns rather than treating an app prediction as a diagnosis.
Lady Technologies publishes support through kegg.tech, including FAQs, a start-up guide, user manual, privacy policy, returns information and support@kegg.tech. The company also links to a Facebook community from its official site. Because fertility products handle sensitive health-related data, privacy and account questions should be routed through the company’s official support channels.
